Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2013 (2013), Article ID 327240, 6 pages
http://dx.doi.org/10.1155/2013/327240
Research Article

The Effect of Mirtazapine on Cisplatin-Induced Oxidative Damage and Infertility in Rat Ovaries

1Department of Pharmacology, Faculty of Medicine, Recep Tayyip Erdogan University, 53100 Rize, Turkey
2Department of Biochemistry, Faculty of Pharmacy, Ataturk University, 25240 Erzurum, Turkey
3Obstetrics and Jinecology Clinic, Sorgun State Hospital, 66700 Yozgat, Turkey
4Department of Pharmacology, Faculty of Medicine, Ataturk University, 25240 Erzurum, Turkey

Received 11 March 2013; Accepted 4 April 2013

Academic Editors: J.-T. Cheng, H. Luddens, M. Makishima, and J. B. T. Rocha

Copyright © 2013 Durdu Altuner et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Pabla and Z. Dong, “Cisplatin nephrotoxicity: mechanisms and renoprotective strategies,” Kidney International, vol. 73, no. 9, pp. 994–1007, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Tangir, D. Zelterman, W. Ma, and P. E. Schwartz, “Reproductive function after conservative surgery and chemotherapy for malignant germ cell tumors of the ovary,” Obstetrics & Gynecology, vol. 101, no. 2, pp. 251–257, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. M. S. Yucebilgin, M. C. Terek, A. Ozsaran et al., “Effect of chemotherapy on primordial follicular reserve of rat: an animal model of premature ovarian failure and infertility,” Australian and New Zealand Journal of Obstetrics and Gynaecology, vol. 44, no. 1, pp. 6–9, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Jemal, T. Murray, A. Samuels, A. Ghafoor, E. Ward, and M. J. Thun, “Cancer statistics, 2003,” Ca-A Cancer Journal for Clinicians, vol. 53, no. 1, pp. 5–26, 2003. View at Google Scholar · View at Scopus
  5. M. Sommezer and K. Oktay, “Fertility reservation in female patients,” Human Reproduction Update, vol. 10, no. 3, pp. 251–266, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Oktay, E. Buyuk, N. Libertella, M. Akar, and Z. Rosenwaks, “Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation,” Journal of Clinical Oncology, vol. 23, no. 19, pp. 4347–4353, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. I. Chirino and J. Pedraza-Chaverri, “Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity,” Experimental and Toxicologic Pathology, vol. 61, no. 3, pp. 223–242, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. N. I. Weijl, A. Wipkink-Bakker, E. G. W. M. Lentjes, H. M. Berger, F. J. Cleton, and S. Osanto, “Cisplatin combination chemotherapy induces a fall in plasma antioxidants of cancer patients,” Annals of Oncology, vol. 9, no. 12, pp. 1331–1337, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. L. M. Greggi Antunes, J. D'arc, and M. D. L. P. Bianchi, “Protective effects of vitamin C against cisplatin-induced nephrotoxicity and lipid peroxidation in adult rats: a dose-dependent study,” Pharmacological Research, vol. 41, no. 4, pp. 405–411, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Wozniak, A. Czechowska, and J. Blasiak, “Cisplatin-evoked DNA fragmentation in normal and cancer cells and its modulation by free radical scavengers and the tyrosine kinase inhibitor STI571,” Chemico-Biological Interactions, vol. 147, no. 3, pp. 309–318, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. M. M. Berger, A. Shenkin, J. P. Revelly et al., “Copper, selenium, zinc, and thiamine balances during continuous venovenous hemodiafiltration in critically ill patients,” The American Journal of Clinical Nutrition, vol. 80, no. 2, pp. 410–416, 2004. View at Google Scholar · View at Scopus
  12. M. D. Kopelman, A. D. Thomson, I. Guerrini, and E. J. Marshall, “The korsakoff syndrome: clinical aspects, psychology and treatment,” Alcohol and Alcoholism, vol. 44, no. 2, pp. 148–154, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Ohkawa, N. Ohishi, and K. Yagi, “Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction,” Analytical Biochemistry, vol. 95, no. 2, pp. 351–358, 1979. View at Google Scholar · View at Scopus
  14. H. Wei and K. Frenkel, “In vivo formation of oxidized DNA bases in tumor promoter-treated mouse skin,” Cancer Research, vol. 51, no. 16, pp. 4443–4449, 1991. View at Google Scholar · View at Scopus
  15. P. N. Bories and C. Bories, “Nitrate determination in biological fluids by an enzymatic one-step assay with nitrate reductase,” Clinical Chemistry, vol. 41, no. 6, pp. 904–907, 1995. View at Google Scholar · View at Scopus
  16. H. Moshage, B. Kok, J. R. Huizenga, and P. L. M. Jansen, “Nitrite and nitrate determinations in plasma: a critical evaluation,” Clinical Chemistry, vol. 41, no. 6, pp. 892–896, 1995. View at Google Scholar · View at Scopus
  17. J. Sedlak and R. H. Lindsay, “Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent,” Analytical Biochemistry, vol. 25, no. C, pp. 192–205, 1968. View at Google Scholar · View at Scopus
  18. R. A. Lawrence and R. F. Burk, “Glutathione peroxidase activity in selenium deficient rat liver,” Biochemical and Biophysical Research Communications, vol. 71, no. 4, pp. 952–958, 1976. View at Google Scholar · View at Scopus
  19. Y. Sun, L. W. Oberley, and Y. Li, “A simple method for clinical assay of superoxide dismutase,” Clinical Chemistry, vol. 34, no. 3, pp. 497–500, 1988. View at Google Scholar · View at Scopus
  20. M. K. Shigenaga, E. N. Aboujaoude, Q. Chen, and B. N. Ames, “Assays of oxidative DNA damage biomarkers 8-oxo-2'-deoxyguanosine and 8- oxoguanine in nuclear DNA and biological fluids by high-performance liquid chromatography with electrochemical detection,” Methods in Enzymology, vol. 234, pp. 16–33, 1994. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Kaur and B. Halliwell, “Measurement of oxidized and methylated DNA bases by HPLC with electrochemical detection,” Biochemical Journal, vol. 318, no. 1, pp. 21–23, 1996. View at Google Scholar · View at Scopus
  22. R. A. Floyd, J. J. Watson, P. K. Wong, D. H. Altmiller, and R. C. Rickard, “Hydroxyl free radical adduct of deoxyguanosine: sensitive detection and mechanisms of formation,” Free Radical Research Communications, vol. 1, no. 3, pp. 163–172, 1986. View at Google Scholar · View at Scopus
  23. S. Asami, T. Hirano, R. Yamaguchi, Y. Tomioka, H. Itoh, and H. Kasai, “Increase of a type of oxidative DNA damage, 8-hydroxyguanine, and its repair activity in human leukocytes by cigarette smoking,” Cancer Research, vol. 56, no. 11, pp. 2546–2549, 1996. View at Google Scholar · View at Scopus
  24. L. M. Pogach, Y. Lee, S. Gould, W. Giglio, M. Meyenhofer, and H. F. S. Huang, “Characterization of cis-platinum-induced Sertoli cell dysfunction in rodents,” Toxicology and Applied Pharmacology, vol. 98, no. 2, pp. 350–361, 1989. View at Google Scholar · View at Scopus
  25. V. T. DeVita Jr., S. Hellman, and S. A. Rosenberg, Cancer: Principals and Practice of Oncology, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 7th edition, 2005.
  26. A. W. Girotti, “Lipid hydroperoxide generation, turnover, and effector action in biological systems,” Journal of Lipid Research, vol. 39, no. 8, pp. 1529–1542, 1998. View at Google Scholar · View at Scopus
  27. B. Borekci, O. E. Yapca, M. I. Turan, M. A. Gul, and U. Isaoglu, “Preventıon of ovarian oxidative stress—related infertility associated with cisplatin in rats with thiamine pyrophosphate,” Latin American Journal of Pharmacy. In press.
  28. U. Isaoglu, M. Yilmaz, E. Sener et al., “The impaired balances of oxidant/antioxidant and COX-1/COX-2 in ovarian ischemia-reperfusion injury and prevention by nimesulide,” Latin American Journal of Pharmacy, vol. 31, no. 10, pp. 1481–1488, 2012. View at Google Scholar
  29. R. J. Korthuis and D. N. Granger, “Reactive oxygen metabolites, neutrophils, and the pathogenesis of ischemic-tissue/reperfusion,” Clinical Cardiology, vol. 16, no. 4, pp. I19–I26, 1993. View at Google Scholar · View at Scopus
  30. M. T. Sener, E. Sener, A. Tok et al., “Biochemical and histologic study of lethal cisplatin nephrotoxicity prevention by mirtazapine,” Pharmacological Reports, vol. 64, no. 594, pp. 594–602, 2012. View at Google Scholar
  31. A. Kisaoglu, B. Borekci, O. E. Yapca, H. Bilen, and H. Suleyman, “Tissue damage and oxidant/antioxidant balance,” Euroasian Journal of Medicine, no. 45, pp. 47–49, 2013. View at Google Scholar
  32. M. L. Urso and P. M. Clarkson, “Oxidative stress, exercise, and antioxidant supplementation,” Toxicology, vol. 189, no. 1-2, pp. 41–54, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. I. S. Young and J. V. Woodside, “Antioxidants in health and disease,” Journal of Clinical Pathology, vol. 54, no. 3, pp. 176–186, 2001. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Nordberg and E. S. J. Arnér, “Reactive oxygen species, antioxidants, and the mammalian thioredoxin system,” Free Radical Biology and Medicine, vol. 31, no. 11, pp. 1287–1312, 2001. View at Publisher · View at Google Scholar · View at Scopus
  35. A. P. Grollman and M. Moriya, “Mutagenesis by 8-oxoguanine: an enemy within,” Trends in Genetics, vol. 9, no. 7, pp. 246–249, 1993. View at Publisher · View at Google Scholar · View at Scopus
  36. P. Jordan and M. Carmo-Fonseca, “Molecular mechanisms involved in cisplatin cytotoxicity,” Cellular and Molecular Life Sciences, vol. 57, no. 8-9, pp. 1229–1235, 2000. View at Google Scholar · View at Scopus
  37. M. Ingec, U. Isaoglu, M. Yilmaz et al., “Prevention of ischemia-reperfusion injury in rat ovarian tissue with the on-off method,” Journal of Physiology and Pharmacology, vol. 62, no. 5, pp. 575–582, 2011. View at Google Scholar
  38. C. Farrell, C. Heaven, K. Beaver, and P. Maguire, “Identifying the concerns of women undergoing chemotherapy,” Patient Education and Counseling, vol. 56, no. 1, pp. 72–77, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. K. M. Anderson, M. Sharpe, A. Rattray, and D. S. Irvine, “Distress and concerns in couples referred to a specialist infertility clinic,” Journal of Psychosomatic Research, vol. 54, no. 4, pp. 353–355, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. K. Kainz, “The role of the psychologist in the evaluation and treatment of infertility,” Women's Health Issues, vol. 11, no. 6, pp. 481–485, 2001. View at Publisher · View at Google Scholar · View at Scopus
  41. R. B. King, “Subfecundity and anxiety in a nationally representative sample,” Social Science & Medicine, vol. 56, no. 4, pp. 739–751, 2003. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Bilici, C. Ozturk, H. Dursun et al., “Protective effect of mirtazapine on indomethacin-induced ulcer in rats and its relationship with oxidant and antioxidant parameters,” Digestive Diseases and Sciences, vol. 54, no. 9, pp. 1868–1875, 2009. View at Publisher · View at Google Scholar · View at Scopus